1American Thoracic Society. Dyspnoea: mechanisms, assessment and management: a consensus statement[J]. Am J Respir Crit Care Med, 1999,159: 321 - 340
2Jennings AL, Davies AN, Higgins JPT, et al. Opioids for the palliation of breathlessness in terminal illness[J]. Cochrane Dattabase Syst Rev, 2002,4:1 - 33
3Jennings AL, Davies AN, Higgins JPT, et al. A systematic review of the use of pioids in the management of dyspnoea[J] .Thorax,2002,57:939 - 944
4Polosa R,Simidchiev A, Walters EH.Nebulised morphine for severe interstitial lung disease[J] .The Cochrane Database Syst Rev,2004,1
5Varkey, Basil MDFCCP. Palliative care for end-stage lung disease patients [J]. Clinical Pulmonary Medicine, 2003,10(5) :269 - 277
6Cohen MH, Anderson AJ, Krasnow SH, et al. Continunous intravenous infusion of morphine for severe dyspnea[J] .South Med J, 1991,84:229 - 234
7Booth S, Kelly MJ, Cox NP, et al. Dose oxygen help dyspnea inpatients with cancer[J]. Am J Respir Crit Care Med, 1996,153:1515 - 1518
8Doorley J, Hobbs M, Delaney E, et al. The role of nebulized opioids in managing terminal dyspnea: implications for the clinical nurse specialist [J]. Clinical Nurse Specialist, 2003,17( 1 ): 19 - 21
9Paiffer C,Poline J-B,Thivard L, et al. Neural substrates for the perception of acutely induced dyspnoea[J] .Am J Rsepir Care Med,2001,163:951 - 957
10Hseih J-C, Belfrage B, Stone-Elander S, et al. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography [J]. Pain, 1995,63:225 - 236
5Levy M H, Back A, Bazargan S, et al. Palliative Care. National Comprehensive Cancer Network . Clinical practice guidelines in ontology [J]. J Nail Compr Cane Netw, 2006,4(8): 776-818.
6Bonnichon A, Le Floch H, Riviere F, et al. Dyspnea in lung cancer [J]. Rev Pneumol Clini, 2008, 64(2) : 62-68.
7Mazzocato C, Buclin T, Rapin C H. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized doubleblind controlled trial [J]. Ann Oncol, 1999, 10 (12): 1511-1514.
8Navigante A H, Cerchiietti L C, Castro M A, et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer [J]. Pain Symptom Manage, 2006,31(1):38-47.
9Cohen M H, Anderson A J, Krasnow S H, et al. Continuous intravenous infusion of morphine for severe dyspnea [J]. South Med J, 1991,84(2): 229-234.
10Boyd K J, Kelly M. Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer [J]. Palliat Med, 1997, 11(4): 277-281.
